Management of Short Bowel Syndrome in adults: a literature review
DOI:
https://doi.org/10.55892/jrg.v7i15.1476Keywords:
Adults, Clinical management, Parenteral nutrition, Short bowel syndrome, TeduglutideAbstract
This study aims to identify current literature recommendations for the management of Short Bowel Syndrome (SBS) in adults, a rare and multifactorial clinical entity with few robust evidences and conducted in a heterogeneous manner. A qualitative research was conducted in databases, selecting relevant articles published in the last five years. In this sense, it became evident that there is consensus regarding the use of nutritional support modalities, especially parenteral nutrition, surgical techniques, and the use of teduglutide, the only GLP-2 analog approved for this purpose, with minor points of divergence identified regarding some criteria and recommendations for the initiation of these therapies. Furthermore, the management of disease complications presents peculiarities that require specialized attention. Finally, many studies are under development, indicating a promising future with innovative therapies that have the potential to significantly improve patients' quality of life. However, further studies and more evidence are needed for these new approaches to be safely implemented in clinical practice, along with the formulation of guidelines that can guide healthcare professionals in managing this challenging condition.
Downloads
References
BERING, Jamie; DIBAISE, John K. Short bowel syndrome: complications and management. Nutrition in Clinical Practice, [S.L.], v. 38, n. 1, p. 46-58, 28 abr. 2023. DOI: 10.1002/ncp.10978.
BOLOGNANI, F.; GAL, P.; MOERLAND, M.; KRUITHOF, A.; VAN GENT, M.; SCHULTHESS, P.; MACHACEK, M.; GREIG, G.; SANTARELLI, L.; MEYER, C. The pharmacokinetic and pharmacodynamic relationship between apraglutide and citrulline: a randomized, placebo-controlled, double-blind study in healthy volunteers. Clinical Nutrition ESPEN, [S.L.], v. 40, p. 413-414, dez. 2020. DOI: 10.1016/j.clnesp.2020.09.035. Acesso em: 12 out. 2024.
DREUILLE, Brune de; FOURATI, Salma; JOLY, Francisca; LE BEYEC-LE BIHAN, Johanne; LE GALL, Maude. Le syndrome de grêle court chez l’adulte. Médecine/Sciences, [S.l.], v. 37, n. 8-9, p. 742-751, ago. 2021. DOI: 10.1051/medsci/2021110. Acesso em: 13 out. 2024.
JEPPESEN, P. B.; VANUYTSEL, T.; SUBRAMANIAN, S.; JOLY, F.; WANTEN, G.; LAMPRECHT, G.; KUNECKI, M.; RAHMAN, F.; NIELSEN, T. S.; GRAFF, L. B. 66 - Glepaglutide induces meaningful clinical improvement in patients with short bowel syndrome chronic intestinal failure. Transplantation, v. 107, n. 7, p. 39-39, 27 jun. 2023. DOI: 10.1097/01.tp.0000945720.64507.04.
JEPPESEN, P. B.; VANUYTSEL, T.; SUBRAMANIAN, S.; JOLY, F.; WANTEN, G.; LAMPRECHT, G.; KUNECKI, M.; RAHMAN, F.; NIELSEN, T. S.; GRAFF, L. B. P42 - Glepaglutide, a long-acting GLP-2 analog, significantly reduces need for parenteral support in short bowel syndrome patients: results of EASE SBS-1, a randomized, double-blind, 24-week phase 3 trial. Transplantation, v. 107, n. 7, p. 39-39, 27 jun. 2023. DOI: 10.1097/01.tp.0000945720.64507.04.
MIZUSHIMA, Tsunekazu; UDAGAWA, Eri; HASEGAWA, Miyuki; TAZUKE, Yuko; OKUYAMA, Hiroomi; FERNANDEZ, Jovelle; NAKAMURA, Shiro. Etiologies and treatments of chronic intestinal failure-short bowel syndrome (SBS) in Japanese adults: a real-world observational study. Surgery Today, [S.l.], v. 52, n. 9, p. 1350-1357, 23 fev. 2022. Disponível em: DOI: 10.1007/s00595-022-02469-9. Acesso em: 12 out. 2024.
MOREIRA, E.; SILVA, L.; OLANO, E.; SOLAR, H. Reabilitação do intestino utilizando um análogo semissintético do peptídeo 2 similar ao glucagon: primeira experiência com teduglutide no Uruguai. Revista Médica del Uruguay (online), v. 37, n. 3, e704, 2021. Disponível em: https://doi.org/10.29193/rmu.37.3.14. Acesso em: 13 out. 2024.
SILVA, Raul; GUERRA, Paula; ROCHA, Anabela; CORREIA, Miguel; FERREIRA, Ricardo; FONSECA, Jorge; LIMA, Eduardo; OLIVEIRA, António; GOMES, Marta Vargas; RAMOS, Diogo. Clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure in Portugal (PARENTERAL Study). GE - Portuguese Journal of Gastroenterology, [S.l.], v. 30, n. 4, p. 293-304, 8 set. 2022. Disponível em: DOI: 10.1159/000526059. Acesso em: 12 out. 2024.
VÍLCHEZ-LOPEZ, F. J.; LARRÁN-ESCANDÓN, L.; GARCÍA ALMEIDA, J. M.; ARRAIZA IRIGOYEN, C.; IRLES ROCAMORA, J. A.; MOLINA-PUERTA, M. J.; MOLINA SORIA, J. B.; PEREIRA CUNILL, J. L.; RABAT RETREPO, J. M.; REBOLLO-PÉREZ, M. I.; SERRANO AGUAYO, M. P.; TENORIO-JIMÉNEZ, C.; OLVEIRA, G.; GARCÍA LUNA, P. P. Evidence-based recommendations of the Andalusian Group for Nutrition Reflection and Investigation (GARIN) for the management of adult patients with short bowel syndrome. Nutr Hosp., v. 38, n. 6, p. 1287-1303, 2021. DOI: 10.20960/nh.03705.
ZORZETTI, Noemi; D’ANDREA, Vito; LAURO, Augusto. Proteomic biomarkers in short bowel syndrome: are we ready to use them in clinical activity? Expert Review of Proteomics, v. 18, n. 9, p. 755-764, 2021. DOI: 10.1080/14789450.2021.1924063.
